Browse > Article
http://dx.doi.org/10.5352/JLS.2014.24.4.437

Comparison of the Properties of Almotriptan PVA Hydrogel Depending on the Ratio of PEG and Confirmation of Potential as Transdermal Formulation  

Kang, Se Mi (Department of Biomaterials Science, College of Natural Resources and Life Science, Pusan National University)
Jung, Young Jin (Department of Biomaterials Science, College of Natural Resources and Life Science, Pusan National University)
Lee, Jae Ho (Department of Biomaterials Science, College of Natural Resources and Life Science, Pusan National University)
Publication Information
Journal of Life Science / v.24, no.4, 2014 , pp. 437-446 More about this Journal
Abstract
Problems appear when triptans are taken orally. For example, the bioavailability of triptan is reduced by the digestive system, and the drug level in the blood reduces rapidly over time; there is also a possibility of gastrointestinal disorder. To improve side effects, a transdermal patch has been prepared in hydrogel form. The polymer matrix that makes up the hydrogel uses PVA; PEG is used as an additive to induce inter/intra hydrogen bonding of the PVA and almotriptan drug is added. In addition, to accelerate micro-phase separation between PVA chains, liquid nitrogen is used. In FT-IR analysis, the absorption bands of PVA, PEG, and almotriptan were found. The degree of crystallinity, the water uptake ability and tensile strength were increased with increasing PEG content. In drug release tests, the amount of drug released increased depending on the PEG content. In this study, hydrogels with 10 wt% PEG showed better performance in drug release. Approximately 60% of the total drug amount was released in 2 hr, and the drug continued to release for 1 day. Thus, the prepared hydrogel patch is suitable as a transdermal formulation for the second dose administration of triptans to patients who require recurrent migraine treatment within 24 hr after the first administration.
Keywords
Almotriptan; drug release; Hydrogel; PEG; PVA;
Citations & Related Records
Times Cited By KSCI : 5  (Citation Analysis)
연도 인용수 순위
1 Al-Qadhi, M., Merah, N. and Gasem, Z. M. 2013. Mechanical properties and water uptake of epoxy-clay nanocomposites containing different clay loadings. J Mater Sci 48, 3798-3804.   DOI
2 An, E. J., Shim, J. W., Choi, J. W., Kim, J. W., Park, W. S., Kim, H. K., Park, K. D. and Han, S. S. 2010. Enhanced transdermal delivery of drug compounds using scalable and deformable ethosomes. J Soc Cosmet Scientists Korea 36, 105-113.   과학기술학회마을
3 Chen, L. C. and Ashcroft, D. M. 2008. Meta-analysis of the efficacy and safety of zolmitriptan in the acute treatment of migraine. Headache 48, 236-247.
4 Choi, D. S., Lee, D. Y. and Yoon, B. K. 2012. Effects of transdermal estrogen gel in postmenopausal Korean woman. J Korean Soc Menop 18, 113-118.   DOI
5 Chung, C. S. 2007. Drugs therapy for migraine. J Korean Med Assoc 50, 917-923.   DOI
6 Drury, J. L. and Mooney, D. J. 2003. Hydrogels for tissue engineering: scaffold design variables and applications. Biomaterials 24, 4337-4351.   DOI   ScienceOn
7 Eun, J. B., Shin, B. K., Nho, Y. C., Lim, Y. M., Park, J. S., Park, J. S., Park, J. S. and Huh, K. M. 2012. Preparation of poloxamer based hydrogels using electron beam and their evaluation for buccal mucoadhesive drug delivery. Polymer (Korea) 36, 182-189.   과학기술학회마을   DOI   ScienceOn
8 Wang, H. R., Kim, H. B. and Lee, S. Y. 2013. Structural and Optical Properties of Multilayer Films of IGZO / Ag / IGZO for Low emissivity applications. J KIEEME 26, 321-324.   과학기술학회마을   DOI   ScienceOn
9 Suneetha, A. and Sundar, B. S. 2010. A validate RP-HPLC method for estimation of almotriptan malate in pharmaceutical dosage form. J Chin Chem Soc 57, 1067-1070.   DOI
10 Suthisisang, C. C., Poolsup, N., Suksomboon, N., Lertpipopmetha, V. and Tepwitukgid, B. 2010. Meta-analysis of the efficacy and safety of naproxen sodium in the acute treatment of migraine. Headache 50, 808-818.   DOI   ScienceOn
11 Tfelt-Hansen, P., De Vries, P. and Saxena, P. R. 2000. A comparative review of pharmacology, pharmacokinetics and efficacy of triptans in migraine. Drugs 60, 1259-1287.   DOI   ScienceOn
12 Wiehe, M., Fuchs, S. C., Moreira, L. B., Moraes, R. S. and Fuchs, F. D. 2002. Migraine is more frequent in individuals with optimal and normal blood pressure: a populationbased study. J Hypertension 20, 1303-1306.   DOI   ScienceOn
13 Zhao, L., Mitomo, H., Nagasawa, N., Yoshii, F. and Kume, T. 2003. Radiation synthesis and characteristic of the hydrogels based on carboxymethylated chitin derivatives. Carbohydr Polym 51, 169-175.   DOI   ScienceOn
14 Sandrini, G., Perrotta, A., Leal, N. L. A., Buscone, S. and Nappi, G. Almotriptan in the treatment of migraine. Neuropsychiatric Disease and Treatment 3, 799-809.
15 Prasad, R., Koul, V. and Khar, R. 2005. Transdermal iontophoretic delivery of methotrexate: physicochemical considerations. Trends Biomater Artif Organs 19, 18-25.
16 Prasad, U. V., Bab, M. S. and Ramu, B. K. 2012. Visible spectrophotometic analysis of almotriptan malate in bulk and formulations. Int J Scien Tech Res 1, 86-91.
17 Suneetha, A., Ravi teja, R. and Kathirvel, S. 2012. Spectrophotometric estimation of amotriptan malate in bulk and pharmaceutical formulations by multivariate technique. Int J Medici Chem Anal 2, 76-80.
18 Schuetz, Y. B., Naik, A., Guy, R. H. and Kalia, Y. N. 2005. Emerging strategies for the transdermal delivery of peptide and protein drugs. Expert Opin Drug Deliv 2, 533-548.   DOI   ScienceOn
19 Shingada, G. M., Aamer, Q., Sabale, P. M., Grampurohit, N. D., Gadhave M. V., Jadhav, S. L. and Gaikwaed, D. D. 2012. Recent trend on transdermal drug delivery system. J Drug Delivery Therapeutics 2, 66-75.
20 Stasko, J., Kalnins, M., Dzene, A. and Tupureina, V. 2009. Polyvinyl alcohol hydrogels. Proc Est Acad Sci 58, 63-66.   DOI
21 Kopecek, J. 2007. Hydrogel biomaterials: A smart future. Biomaterials 28, 5185-5192.   DOI   ScienceOn
22 Lavudu, P., Rani, A. P., Divya, C., Sekaran, C. B. 2013. High performance liquid chromatographic analysis of almotriptan malate in bulk and tablets. Adv Pharm Bull 3, 183-188.
23 Kobayashi, M., Toguchida, J. and Oka, M. 2003. Preliminary study of polyvinyl alcohol-hydrogel (PVA-H) artificial meniscus. Biomaterials 24, 639-647.   DOI   ScienceOn
24 Kochhar, C. and Lmanidis, G. 2004. In-vitro transdermal iontophoretic delivery of leuprolide under constant current application. J Contro Release 98, 25-35.   DOI   ScienceOn
25 Lee, K. Y., Bouhaddir, K. H. and Mooney, D. J. 2000. Degradation behavior of covalently cross-linked polyaldehyde guluronate hydrogels. Macromol 33, 97-101.   DOI   ScienceOn
26 Lim, C. S., Oh, S. H., Jeon, H. J., Song, H. H. and Lee, J. H. 2010. Fabrication and characterization of polyvinyl alcohol hydrogel beads by quenching technique for the treatment of urinary incontinence. Biomat Res 14, 186-194.
27 Jan, T. and Sebastien, K. 2005. Pathogenesis and therapy for idiopathic dyspepsia. Curr Gastro Rep 7, 437-444.   DOI   ScienceOn
28 Michel, M., Hartmann, M., Gemmer, J. and Mahler, G. 2003. Fourier's Law confirmed for a class of small quantum systems. Eur Phys J B 34, 325-330.   DOI   ScienceOn
29 Mignani, S., Kazzouli, S. E., Bousmina, M. and Majoral, J. P. 2013. Expand classical drug administration ways by emerging routes using dendrimer drug delivery systems: A concise overview. Adv Drug Deliv Rev 65, 17-20.   DOI   ScienceOn
30 Mutalik, S., Udapa, N. and Kumar, S. 2006. Glipizide matrix transdermal system for diabetes mellitus : in-vitro and preclinical studies. Life Sci 79, 1568-1577.   DOI   ScienceOn
31 Hemangi, J. P., Jitendra, S. P., Desai, B. G. and Keyur, D. P. 2010. Permeability studies of anti-hypertensive drug amlodipine besilate for transdermal delivery. Asian J Pharm and Clin Res, 3. 31-34
32 Hoffman, A. S. 2002. Hydrogels for biomedical applications. Adv Drug Deliv Rev 54, 3-12.   DOI   ScienceOn
33 Jin, H. E., Kim, J. H. and Park, I. Y. 2005. Transdermal drug delivery system. J Korean Ind Eng Chem 16, 15-20.   과학기술학회마을
34 Kazmierczak, A. 2004. The new ring seal of the combustion engines and its surface free energy. Ind Lubri Tribo 56, 6-13.   DOI
35 Kim, S. J. 2011. A study on transdermal drug delivery system with microneedle system in the field of skin care. Korean Soc Biotech Bioeng 26. 277-282.   과학기술학회마을   DOI   ScienceOn
36 Hassan, C. M. and Peppas, N. A. 2000. Structure and applications of polyvinyl alcohol hydrogels produced by conventional crosslinking or by freezing / thawing methods. Adv Polym Sci 153, 37-65.   DOI
37 Kinoshita, M., Yamamoto, R. and Kominami, K. 2011. In-vitro and in-vivo transdermal iontophoretic delivery of tramadol, a centrally acting analgesic. J Pharm Pharmacol 63, 1437-1445.   DOI   ScienceOn
38 Ferrari, M. D., Roon, K. I., Lipton, R. B. and Goadsby, P. J. 2001. Oral triptans (serotonin, $5-HT_{1B/1D}$ agonists) in acute migraine treatment, ameta-analysis of 53trials. Lancet 358, 1668-1675.   DOI   ScienceOn
39 Figueroa, M., Charro, D. and Mendez, J. 2001. Passive and iontophoretic transdermal penetration of methotrexate. Int J Pharm 212, 101-107.   DOI   ScienceOn
40 Bodugoz S. H., Choi, J., Oral, E., Kung, J. H., Macias, C. E., Braithwaite, G. and Muratoglu, O. K. 2008. The effect of polyethylene glycol on the stability of pores in polyvinyl alcohol hydrogels during annealing. Biomat erials 29, 141-149.   DOI   ScienceOn
41 Prasad, U. V., Bab, M. S. and Ramu, B. K. 2012. Development of new visible spectrophotometric methods for quantitative determination of almotriptan malate as an active pharmaceutical ingredient formulations. Int J Drug Dev Res 4, 369- 374.
42 Lavudu, P., Rani, A. P., Divya, C., Sekaran, C. B. 2013. Development and validation of HPLC method for the determination of almotriptan malate in bulk and tablet dosage forms. Int J Pharm Tech Res 5, 459-466.
43 Hassan, C. M., Ward, J. H. and Peppas, N. A. 2000. Modeling of crystal dissolution of polyvinyl alcohol gels produced by freezing / thawing processes. Polym 41, 6729-6739.   DOI   ScienceOn
44 Stammen, J. A., Williams, S., Ku, D. N. and Guldberg, R. E. 2001. Mechanical properties of a novel PVA hydrogel in shear and unconfined compression. Biomaterials 22, 799-806.   DOI   ScienceOn